Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Sophie V. Vandebroek
Director
Disclosures on record
10
Companies involved
2
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Director sold
~$594KReported value · 945 sh @ $628.646
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1
A board member of Idexx Laboratories sold $594K of Idexx Laboratories shares. Nobody planned it ahead of time.
Director sold
~$326KReported value · 519 sh @ $628.56
Stock since the trade -17.3% · S&P 500 +11.9% · to Oct 1
A board member of Idexx Laboratories sold $326K of Idexx Laboratories shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.